For example, we employ flavin cofactors to design next generation of photocatalysts and exploit the properties of biopolymers to ensure uptake of drugs into solid tumours. No matter where we start, we often end up using our molecular tools for applications we have not initially anticipated. The polymers developed for catalysis might be used as contrast agents for senescent cells, and building blocks of drug nanocarriers for the enhancement of biosensors’ activity.

Such diversity of molecular and nanostructured tools, and applications can be achieved only through collaborations with other researchers and our colleagues in industry. Our collaborators include clinicians and cancer biologist, but also engineers and product developers both from small start ups and established companies.